1. Mizuno S., Noda T., Mogushi K., Hase T., Iida Y., Takeuchi K., Ishiwata Y., Uchida S., Nagata M.. Development of a predictive model for vancomycin-associated nephrotoxicity using the area under the concentration-time curve of vancomycin: a machine learning analysis. 2024 AAPS PharmSci 360 2024.10.23

  2. Nagata M., Kusakabe Y., Ishiwata Y.. Oren-gedoku-to, a traditional Chinese medicine, prevents the hyperglycemia caused by chronic olanzapine administration via hypothalamic AMP-activated protein kinase activity. 2024 AAPS PharmSci 360 2024.10.22

  3. Nagata M.. Challenge of predicting drug and side effects using pharmacometrics and machine learning models. DUPHAT2024 2024.01.11

  1. Noda T., Mizuno S., Hase T., Mogushi K., Iida Y., Ishiwata Y., Nagata M.. Using machine learning algorithm to predict the occurrence of nephrotoxicity with tacrolimus. 81st FIP World Congress of Pharmacy and Pharmaceutical Sciences 2023.09.27

  2. Kawano Y., Kawasumi K., Mano Y., Matsui R., Maeda-Minami A., Yamamoto Y., Negishi K., Shimada S., Nagata M., Aoyama T.. Risk factors associated with unplanned acute care in outpatient chemotherapy with oral anticancer drugs as monotherapy or combination therapy with injectable anticancer drugs. 81st FIP World Congress of Pharmacy and Pharmaceutical Sciences 2023.09.26

  1. Masatoshi Takagi, Chitose Ogawa, Tomoko Iehara, Yuki Aoki-Nogami, Eri Isibashi, Minoru Imai, Toshimi Kimura, Masashi Nagata, Masato Yasuhara, Mitsuko Masutani, Kenichi Yoshimura, Daisuke Tomizawa, Atsushi Ogawa, Kan Yonemori, Tetsuro Kihara, Kiyoshi Nobori, Kazuhisa Hasebe, Shuki Mizutani, Tomohiro Morio, Hajime Hosoi, Ryuji Koike. First In Children Phase I Clinical Study Of Oral Olaparib In Pediatric Patients With Refractory Solid Tumors. SIOP2021 2021.10.24 Honolulu(Web)

  1. Yasuhara M., Asada M., Nagata M., Mizuno T., Uchida T., Takahashi H., Makita K., Arai H., Echizen H.. Population pharmacokinetics of cefazoline before, during and after cardiopulmonary bypass in Japanese patients undergoing cardiothoracic surgery. 2019 AAPS PharmSci 360 2019.11

  1. Kawano Y., Nagata M., Arimori K., Kohno T., Ichimiya A., Uehara K., Aoyama T.. Caffeine increases cisplatin-induced apoptosis via inhibition of Akt pathway and ATM-mediated cell cycle checkpoint pathway in HCC cell lines. 2017 AAPS Annual Meeting and Exposition 2017.11.12 San Diego

  2. Nagata M., Kimura Y., Ishiwata Y., Takahashi H., Yasuhara M.. Epinephrine is involved in clozapine-induced acute hyperglycemia. 2017 AAPS Annual Meeting and Exposition 2017.11.12 San Diego

  3. Odaka M., Nagata M., Mizuno T., Uchida T., Takahashi H., Makita K., Arai H., Echizen H., Yasuhara M.. Effect of cardiopuomonary bypass surgery on unbound fraction of cefazolin in plasma. ASCPT 2017 Annual Meeting 2017.03.17 Washington, DC

  1. Ishiwata Y., Nagata M., Arai T., Makiishi M., Yoshikawa M., Takahashi H., Kohsaka H., Yasuhara M.. Drug-drug interaction of miconazole oral gel with tacrolimus and cyclosporine after oral administration. 2016 AAPS Annual Meeting and Exposition 2016.11.13 Denver

  2. Arimori K., Kawano Y., Nagata M., Kohno T., Ichimiya A., Toyama T., Iwakiri T., Okumura M.. Effect of caffeine on the antitumor effect of cisplatin in human hepatocellular carcinoma cells. 76th FIP’s World Congress of Pharmacy and Pharmaceutical Sciences 2016 2016.08.28 Buenos Aires

  3. Nagata M., Nakajima M., Ishiwata Y., Takahashi Y., Takahashi H., Yasuhara M.. Pharmacokinetic-pharmacodynamic modeling of olanzapine-induced acute hyperglycemia in rats. 11th International ISSX Meeting 2016.06.12 Busan

  1. Yasuhara M., Nagata M., Nakajima M, Ishiwata Y., Takahashi H.. Hyperglycemia induced by a single dose of olanzapine in rats. 2015 AAPS Annual Meeting and Exposition 2015.11.12 Orlando

  1. Masashi Nagata, Yasuyoshi Ishiwata, Masato Yasuhara, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. PK-PD modeling of sunitinib-induced thrombocytopenia in patients with renal cell carcinoma.. 2014 AAPS Annual Meeting and Exposition 2014.11.02 San Diego

  1. Shoichi Kojima, Ryosuke Isozaki, Yasuyoshi Ishiwata, Masashi Nagata, Masato Yasuhara, Fusao Kaiho. Effect of phenytoin on busulfan-induced seizures in rats. 日本薬物動態学会第28年会 2013.10.09 東京

  1. Nagata M., Isozaki R., Ishiwata Y., Yasuhara M.. Development of an animal model to investigate the pharmacodynamics of busulfan-induced myoclonus.. 2012 AAPS Annual Meeting and Exposition 2012.10.14 Chicago

  1. Seiji Karakawa, Toru Arino, Yasuyoshi Ishiwata, Masashi Nagata, Masato Yasuhara. Effect of Pentamidine on Serum Glucose Concentration in Rats. 第5回次世代を担う若手医療薬科学シンポジウム 2011.11.26 名古屋

  1. Yanagie H., Morishita Y., Nishimura R., Kakimi K., Sugiyama H., Takamoto S., Higashi S., Ikushima I., Arimori K., Nagata M., Nagasaki T., Imagawa T., Nakashima T., Terao T., Eriguchi M.. Development of epirubicin entrapped WOW emulsion by double emulfication technique to arterial-injection-chemotherapy for hepatocellular carcinoma.. AACR 100th Annual Meeting 2009 2009.04.18 Denver

  1. Hidaka M., Nagata M., Arimori K. Pharmacokinetic interactions of drugs and fruit juices with carbamazepine in rat.. Enrlich II-2nd World Conference on Magic Bullets 2008.10.03 Nurnberg

  1. Tokunaga J., Takamura N., Furuya Y., Motoya T., Hirai M., Nagata M., Kawachi A., Suzuki A., Matsuoka T.. Approach on clinical pharmacy training Ⅲ in Kyushu university of health and welfare (1): a practice of the bed side training and its evaluation by students.. 21st FAPA Congress 2006.11.18 Yokohama

  1. Yasuhara M., Fujichika T., Nagata M.. Pharmacodynamics of cefazolin-induced seizures in rats with experimental renal failure.. 2002 AAPS Annual Meeting and Exposition 2002.11.08 Toronto

  1. Nagata M., Inotsume N., Yasuhara M.. Effect of experimental renal failure on the pharmacodynamics of cefoselis-induced seizures in rats.. Ⅶ World Conference on Clinical Pharmacology and Therapeutics 2000.07.15 Florence

  1. Hiroshi Churei, Hiromi Yoshida, Maya Sugii, Kouta Tsuge, Yuko Sase, Masashi Nagata, Kairi Hayashi, Kaito Togawa, Sachiko Fujino, Kazuyoshi Yagishita. Imformation sharing on the intraoral local use of glucocorticoids. 34th congress of Japan Academy of Sports Dentitry 2023.11.19

To the head of this page.▲